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Abstract
Background: GATA4 is an essential transcription factor required for the development and function of multiple organs.
Despite this important role, our knowledge of how the GATA4 gene is regulated remains limited. To better understand this
regulation, we characterized the 59 region of the mouse, rat, and human GATA4 genes.
Methodology/Principal Findings: Using 59 RACE, we identified novel transcription start sites in all three species. GATA4 is
expressed as multiple transcripts with varying 59 ends encoded by alternative untranslated first exons. Two of these non-
coding first exons are conserved between species: exon 1a located 3.5 kb upstream of the GATA4 ATG site in exon 2, and a
second first exon (exon 1b) located 28 kb further upstream. Expression of both mRNA variants was found in all GATA4-
expressing organs but with a preference for the exon 1a–containing transcript. The exception was the testis where exon 1a–
and 1b–containing transcripts were similarly expressed. In some tissues such as the intestine, alternative transcript
expression appears to be regionally regulated. Polysome analysis suggests that both mRNA variants contribute to GATA4
protein synthesis.
Conclusions/Significance: Taken together, our results indicate that the GATA4 gene closely resembles the other GATA
family members in terms of gene structure where alternative first exon usage appears to be an important mechanism for
regulating its tissue- and cell-specific expression.
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Introduction
TheGATAproteinsareasmallfamilyoftranscriptionalregulators
composed of 6 members that bind the common consensus sequence
motif(A/T)GATA(A/G).GATAproteinsshareahighlyhomologous
zinc finger DNA binding domain which is also highlyconserved from
invertebrates to mammals [1]. GATA family members display
distinctive but overlapping expression patterns, both temporally and
spatially. GATA1, 2, and 3 are primarily expressed in cells of the
hematopoietic lineage (e.g., primitive erythroblasts, megakaryocytes,
T cells, eosinophils),embryonic brain and liver,testis, and endothelial
cells [2–4]. Conversely, GATA4, 5, and 6 are primarily detected in
mesoderm- and endoderm-derived tissues such as the heart, lung,
stomach, intestine, gonads, and blood vessels [3,5,6]. In agreement
with these expression patterns, numerous GATA knockout models in
mice as well as the in vitro identification of GATA target genes have
revealed the crucial role of GATA factors for cellular differentiation
during vertebrate organogenesis [2,5,6].
GATA4 is prominently expressed during embryogenesis in
developing endoderm and mesoderm and their derivatives
including the liver, intestine, stomach, pancreas, and gonads
[7–14]. In the mouse, Gata4 deficiency leads to early embryonic
lethality due to deficiencies in the differentiation of the
extraembryonic endoderm leading to misclosure of the ventral
wall of the embryo and an inability to form a linear heart tube
[15,16]. Later studies, using tetraploid embryo complementation
to rescue these lethal defects, revealed a definitive role for GATA4
in early cardiogenesis [17], and that GATA4, together with
GATA6, is required for the onset of cardiac myocyte gene
expression and differentiation [18]. The characterization of
embryos generated from Gata4 null ES cells by tetraploid
complementation also revealed the essential role of GATA4 in
early development of the liver and ventral pancreas [19]. In Gata4
null embryos, the gut tube fails to close, again due to defects in
visceral endoderm differentiation [15,16]. Analysis of Gata4
2/2
chimeric mice showed that GATA4 is also required for proper
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into the essential nature of GATA4 in stomach development has
come from mice expressing a mutant form of GATA4 (Gata
ki/ki)
that can no longer interact with its partner FOG2 [21]. The same
mice were also used to demonstrate the role of GATA4 in early
gonad development [22–24]. The ever-expanding list of GATA4
target genes have helped to define the pivotal role of this
transcription factor in the molecular cascade of events in early
organogenesis and proper organ function later in life [5,6,25–28].
Although many GATA4 target genes have been identified, and
despite the importance of this factor in many developmental processes,
our knowledge of how the GATA4 gene is regulated remains
surprisingly limited. Initial identification of Gata4 transcripts was
made by screening of cDNA libraries [7,13]. The identified sequences
included an untranslated first exon located 3.5 kb upstream of the
ATG initiator codon in exon 2. We and others have begun to
characterize the regulation of mouse Gata4 transcription via regulatory
sequences immediately upstream of this non-coding first exon [29,30].
In both cardiac and gonadal cells, conserved GC boxes and an E-box
element immediately upstream of its transcription initiation site
appear to play an important role [29,30].
Interestingly, the structural organization of the different
vertebrate GATA genes shows several common features, including
the use of multiple variably distant enhancers and the presence of
alternative 59 untranslated exons whose expression is controlled by
distinct, and often tissue-specific, promoter units [31–37]. In the
mouse, the Gata4 gene is regulated by a least one distal enhancer
required for early Gata4 expression in lateral mesoderm and then
eventually in the mesenchyme surrounding the fetal liver [38].
Since the expression of alternative transcripts differing in their 59
ends is an important regulatory feature of many GATA genes [32],
we hypothesized that this regulatory mechanism exists for the
GATA4 gene as well. Therefore, to gain further insights into the
transcriptional regulation of the GATA4 gene, we performed a
detailed analysis of the 59 ends of GATA4 transcripts from different
species generated by rapid amplification of cDNA ends-PCR (59
RACE-PCR). We found that, indeed, the mouse, rat and human
GATA4 genes are expressed as multiple transcripts that differ in
their first exon usage. Two of these exons, named E1a and E1b,
are highly conserved between mammalian species and their
differential usage likely contributes to the tissue- and/or cell-
specific expression of the GATA4 gene.
Results
The Mouse, Rat, and Human GATA4 Genes Are Expressed
as Multiple Transcripts with Alternative Untranslated First
Exons
The initial characterization of GATA4 transcripts showed that
GATA4 transcription begins with an untranslated first exon located
approximately 3.5 kb upstream of its translation initiation site
[7,13]. However, an analysis of the genomic organization of the
other mammalian GATA genes has revealed that they share
several common features, including differential first exon usage
driven by alternative upstream promoters [32]. Surprisingly, a
similar property has not yet been described for the GATA4 gene. A
database search of GATA4 nucleotide sequences, however, has
revealed the presence of at least one EST from a human intestine
cDNA library that shares partial homology to GATA4 but which
differs from the classical sequence in its 59 end (GenBank
AK097060). This provides initial evidence that GATA4 transcripts
with variable 59 termini likely exist. To verify that GATA4 is no
exception to the 59 untranslated exon rule, and to gain additional
insights into the transcriptional mechanisms that regulate GATA4
gene expression, we analyzed the 59 ends of GATA4 transcripts by
59 RACE (Figure 1A and B). RACE reactions were carried out
using RNA isolated from mouse, rat, and human tissue samples
known to express GATA4 (Figure 1A). For the three species
examined, the RACE reaction yielded a major band of similar size
as visualized by electrophoresis in a standard agarose ethidium
bromide-stained gel (Figure 1A, solid arrows). An additional
higher molecular weight minor band was also evident for the
mouse and human samples (Figure 1A, dashed arrows).
Surprisingly, sequence analysis of the products cloned from the
major RACE band in mouse revealed that it contained not one
but rather three distinct cDNAs that differed in their 59 termini.
We found clones containing the expected non-coding first exon of
Gata4 (renamed as E1a) located 3.5 kb upstream of E2 in all tissues
examined (Figure 1B and D). GATA4 E1a-containing transcripts
were equally well represented in the rat and human samples
(Figure 1B). We also identified GATA4 transcripts containing two
novel exons (named E1b and E1b9) approximately 30 kb distant
from E2 (Figure 1D). The E1b9-containing transcript was the least
abundant of the three RACE clones identified and was restricted
to mouse heart and testis (Figure 1B). The heart also expressed a
longer form of the E1b9 transcript (Figure 1A, dashed arrow in left
panel). E1b-containing transcripts, however, were present in all
tissues and all three species (Figure 1B).
RACE clones derived from human tissues samples revealed an
additional first exon (named E1c) located midway between E1a and
E1b (Figure 1D). In both human testis and ovary (Figure 1B),
GATA4 transcripts were identified that contained E1c alone
(Figure 1A, solid arrow in right panel) or E1c joined to E1b
(Figure 1A, dashed arrow). This differed from the mouse and rat
where E1a, E1b, and E1b9 were used independently of one another.
With respect to sequence homology, E1a and E1b were less well
conserved among species than were the other GATA4 coding exons,
especially E2 (Figure S1). Interestingly, E1b displayed a higher
sequence conservation (94.4% between mouse and rat, 69%
between mouse and human) than E1a (72.7% between mouse
and rat, 59.8% between mouse and human). In agreement with the
59 RACE clone distribution (Figure 1B), E1b9 and E1c were not
conserved, and thus appear to be species-specific. Inspection of the
exon/intron boundaries of the different first exons showed that the
sequences at the splice donor sites conform to the AG-gt splice rule
and represent either canonical (E1a, E1b, E1c) or non-canonical
(E1b9) splice sites (Figure 1C). The large distance separating E1a
and E1b (,28 kb) was well conserved between species, as was the
distance between E1 and E2 (,3.5 kb) (Figures 1D and S1).
The identity and tissue distribution of the different GATA4
transcripts were confirmed by conventional RT-PCR using exon
1-specific primers for each species as shown in Figure 2A. All PCR
products were subcloned and sequenced to confirm the identity of
the amplified transcripts. In mouse, Gata4 transcripts containing
E1a were present in all adult organs known to express GATA4
(Figure 2B). The same was true for E1b-containing transcripts
with the exception of the intestine where PCR amplification
was variable (i.e., some times strong, some times weak). Gata4
transcripts containing E1b9 exhibited a more restricted pattern
with expression detected as a doublet band (long and short forms)
only in heart, stomach, and gonads (Figure 2B).
In the rat, Gata4 transcripts containing either E1a or E1b were
also amplified in GATA4-positive tissues such as the testis and
ovary (Figure 2B). Interestingly, amplification with E1a-specific
primers in rat tissues resulted in 2 bands. Sequencing showed that
the higher molecular weight band was the expected transcript and
the lower molecular weight band was an association between E1a
and a shorter part of E2 (Figure 1D, dotted line).
Alternative GATA4 Transcripts
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containingtranscripts (Figure2B).E1bwas amplifiedeitheraloneor
fused with a novel exon, E1c. The E1b-E1c amplified sequence
matched one found in a human intestine EST database (GenBank
AK097060), except that E1c in the EST sequence was connected to
E3 and not E2 as in our clones. E1b-containing transcripts are likely
to havea more complex secondarystructurewhen compared toE1a
transcripts as the calculated free energy value for the E1b sequence
was almost twice as that of the E1a sequence (Figure 2C). Our
conventional PCR studies therefore show that although GATA4
E1b9 and E1c are species-specific, E1a and E1b are well conserved
and are likely physiologically relevant to GATA4 gene regulation in
different tissues. In light of this, the remainder of the present study is
focused on Gata4 E1a and E1b transcripts in mouse tissues.
Figure 1. Identification of GATA4 alternative transcripts. (A) Characterization of alternative 59 GATA4 mRNA ends by 59 RACE of mouse, rat, and
human transcripts obtained from heart (H), liver (L), testis (T), ovary (O), and intestine (I). Negative (water only) controls (2) and the base pair sizes of
molecular weight markers (M) are also shown. Continuous arrows point out each major band while discontinuous arrows point out additional higher
molecular weight bands. (B) Quantitative distribution of the 59 RACE products subcloned in pCRII-TOPO cloning vector and subsequently sequenced;
na: not applicable. (C) Sequences of the splice donor site of intron 1 of the mouse (m), rat (r) and human (h) GATA4 genes. (D) Schematic
representation of the genomic organization of previously known and newly identified untranslated first exons of mouse, rat and human GATA4 loci.
Continuous and dotted lines represent possible first exon associations. Intronic distances between 59 untranslated first exons and between the first
translated exons (E2) and E3 are indicated.
doi:10.1371/journal.pone.0008454.g001
Alternative GATA4 Transcripts
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Non-Coding Exons Are Widely and Coordinately
Expressed in Fetal and Adult Mouse Tissues
In order to study the relative abundance of the different Gata4
mRNA variants in adult mouse tissues, we performed qPCR on
RNA derived from several Gata4-expressing organs (Figure 3).
Gata4 E1a mRNA levels were well correlated with the expected
variation of Gata4 expression in heart, liver and gonads (Figure 3A,
left panel). Highest levels were found in heart and ovary, where the
majority of the cells contain GATA4 protein (Figure 3B, C, and F).
Lower levels of Gata4 E1a transcripts were observed in liver and
testis (Figure 3A, left panel), where only subpopulations of cells
are GATA4-positive (Figure 3D and E). With the exception of
the testis, Gata4 E1b mRNA levels were about 10–20% of those
observed for the E1a variant (Figure 3A, middle panel). A
comparison of E1a vs. E1b transcript expression in the different
tissues showed that the testis, with an E1a/E1b ratio of 1, robustly
expresses the E1b mRNA variant (Figure 3A, right panel).
The intestine was not included in the initial qPCR analysis since
this tissue exhibits a marked anterior-to-posterior decrease in Gata4
expression [39,40]. Expression of the Gata4 E1a and E1b
transcripts in this tissue was therefore studied as a function of
intestinal segment (Figure 4A). Gata4 E1a mRNA levels followed
this classic anterior-to-posterior profile (Figure 4A, left panel).
Gata4 E1b mRNA levels had a similar profile but with a sharp
decrease between the jejunum and ileum (Figure 4A, middle
panel). The E1a/E1b ratio showed that the transcripts were
expressed at a similar level in the anterior part of the tissue
(Figure 4A, right panel). In the more distal segments, this E1a/E1b
ratio was not informative due to the absence of E1b transcripts.
This is likely the reason for the variable detection of the E1b
transcript in our conventional PCR amplifications (Figure 2B). To
better understand Gata4 mRNA variant expression in the intestine,
we made use of our previously reported transgenic mouse line
[29], that expresses a GFP fluorescent reporter under the control
of Gata4 regulatory sequences immediately upstream of E1a (the
25k bGata4 E1a promoter-GFP construct is shown in Figure 4D).
Macroscopic views of adult intestine revealed a patchy pattern of
expression of the GFP transgene (Figure 4B and C). This was
similar to what we observed for Gata4 E1a mRNA detected by in
situ hybridization using an E1a-specific probe (Figure 4G).
Immunohistochemistry analysis confirmed that whereas GATA4
protein was present in all enterocytes of all villosities, with a crypt
to apex gradient (Figure 4E), the GFP transgene (Figure 4F and
H), much like the Gata4 E1a mRNA (Figure 4G), was expressed in
enterocytes of only a subset of villosities. Our data therefore show
that both first exons are expressed in a coordinate fashion in Gata4-
expressing adult organs, with the exception of the lower intestinal
tract.
We further investigated the pattern of Gata4 E1a and E1b
transcript expression by in situ hybridization in mouse fetal organs
(Figure 5). We compared the pattern of expression of all Gata4
transcripts using a coding sequence (cds) riboprobe to exon 1-
specific Gata4 transcripts using E1a and E1b-specific riboprobes.
As expected, using a probe encompassing the whole coding
sequence from E2 to E7, which is a sequence shared by all Gata4
transcripts, we found strong expression in testis cords, hindgut and
intestinal epithelia, differentiating pancreas and hepatic mesen-
chyme at e12.5 (Figure 5A). In the e15.5 testis, global Gata4
transcripts were found in Sertoli cells inside cords, and in scattered
cells in the mesenchyme that corresponded to fetal Leydig cells,
and also in the thin epithelium covering the tunica albuginea,
reminiscent of the coelomic epithelium (Figure 5D). Using a mouse
E1a-specific riboprobe, we observed an expression profile identical
to, albeit at a lower level, that observed using the Gata4 cds
riboprobe (Figure 5B and E). The use of E1b-specific probes was
unsuccessful in in situ analysis both in fetal (Figure 5C and F) and
adult organs (data not shown). The low signal for the E1b
riboprobe was difficult to distinguish from background and the
non-specific signal caused by the sense probes (insets to Figure 5E
Figure 2. GATA4 mRNA variant expression and secondary
structure. (A) Location of primers used for PCR amplification of the
GATA4 mRNA variants; specific 59 primers (indicated on the GATA4
locus) were used in combination with a common 39 primer. (B) RT-PCR
amplification of GATA4 E1a, E1b, and E1b9 mRNA variants in GATA4-
expressing tissues (H, heart; I, intestine; L, liver; S, stomach; T, testis; O,
ovary), and control tissues that weakly or do not express GATA4 (Ln,
lung; B, brain; K, kidney). Tissues were obtained from adult mouse and
rat and from fetal human samples. The identity of the GATA4 mRNA
variants amplified with the human samples was verified by cloning and
sequencing the products. (C) Predicted secondary structures of the
mouse Gata4 E1a or E1b mRNA sequences. The structures were
predicted using the RNA draw program [51]. Calculated free energy
values for the structures were 233.59 kcal/mol for E1a and
258.59 kcal/mol for E1b. Start sites are indicated by concentric circles.
doi:10.1371/journal.pone.0008454.g002
Alternative GATA4 Transcripts
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explained by the more complex secondary structure of the E1b
mRNA sequence (Figure 2C), that could have impeded the
hybridization reaction. It might also be due to the lower level of
expression of the E1b transcript as we observed in our qPCR
analysis of adult organs (Figures 3A and 4A). The Gata4 E1b
transcript might also be absent in the fetal testis despite its strong
expression in the adult testis (Figure 3A). Although the E1b in situ
experiments were inconclusive, our E1a in situ data demonstrate
that Gata4 E1a transcripts are at least expressed in a similar pattern
to that of the Gata4 gene.
Gata4 E1a and E1b Transcripts Are Actively Translated
Since the Gata4 alternative first exons are non-coding, an
immunohistochemical approach using isoform-specific antibodies
could not be used to assess the biological relevance of the E1a and
E1b mRNA variants. To demonstrate that the two Gata4 mRNA
variants are both likely translated into protein, we performed a
polysome analysis of the E1a and E1b transcripts in the adult
mouse testis (Figure 6). In this assay, a sucrose gradient is used to
separate mRNA species associated with monoribosomes located at
the top of the gradient (mRNAs not actively translated) vs. those
associated with polyribosomes at the bottom of the gradient
Figure 3. Quantitative expression of E1a- and E1b-containing Gata4 transcripts in adult mouse organs. (A) Quantitative PCR (qPCR) was
used to assess relative Gata4 E1a and E1b mRNA levels in several organs known to robustly express GATA4; kidney was used as a negative control.
Data are reported in arbitrary units as a ratio of the level of Gata4 E1a or E1b mRNA variant to that of the Rpl19 reference gene 6SEM. Groups with
like letters are not significantly different. The E1a to E1b ratio (E1a level divided by E1b level) indicates the relative proportion of each mRNA in these
organs and highlights the importance of the E1a transcript, except in the testis, where both the E1a and E1b Gata4 mRNA variants are equally
represented (ratio close to 1); nd, not defined. (B–F) Representative GATA4 immunohistochemistry in mouse adult heart atrium (B) and ventricle (C),
liver (D), testis (E) and ovary (F) showing the relative proportion of Gata4-expressing cells in each organ. Scale bars: 100 mm.
doi:10.1371/journal.pone.0008454.g003
Alternative GATA4 Transcripts
PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8454Figure 4. Quantitative expression of E1a- and E1b-containing Gata4 transcripts in mouse intestine. (A) qPCR was used to assess relative
Gata4 E1a and E1b mRNA levels in successive antero-posterior intestine segments. Data are reported in arbitrary units as a ratio of the level of Gata4
E1a or E1b mRNA variant to that of the Rpl19 reference gene 6SEM. Groups with like letters are not significantly different. The E1a to E1b ratio (E1a
level divided by E1b level) indicates the relative proportion of each mRNA in the different intestinal regions and reveals the increasing proportion of
E1a Gata4 mRNA compared to E1b Gata4 mRNA going from the most anterior to the most posterior segments. (B–G) Heterogeneous expression of
Gata4 E1a transcripts in the intestine. Bright field (B) and fluorescent confocal view (C) of adult mouse intestine villosities expressing a GFP transgene
under the control of 5 kb of proximal Gata4 1a promoter sequence (construct is shown in D). Immunohistochemistry for endogenous GATA4 protein
(E). Detection of Gata4 E1a transcripts by in situ hybridization (G) shows a patchy distribution pattern similar to the immunohistochemical detection
of promoter 1a driven GFP expression viewed in either a longitudinal (F) or transverse section (H). Scale bars: 100 mm.
doi:10.1371/journal.pone.0008454.g004
Alternative GATA4 Transcripts
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and E1b transcripts (detected by conventional PCR) were
associated with the heaviest (polyribosomal) fractions located at
the bottom of the gradient indicating that both transcripts are
actively translated into protein. A control experiment, where
EDTA was added to the testis samples and the sucrose gradient to
dissociate the polyribosomes, was included to demonstrate that the
Gata4 E1a and E1b mRNAs were indeed associated with the
polyribosomal fractions.
Discussion
GATA4 is a member of the GATA family of transcriptional
regulators that is required for the development and differentiation
of numerous organs in the early embryo. This pivotal develop-
mental role emphasizes the importance of understanding the
molecular mechanisms that regulate expression of the GATA4
gene. Despite its critical role in organogenesis, our knowledge of
GATA4 gene transcription remains surprisingly limited. Here, we
report the identification of novel GATA4 transcripts that differ
solely in their non-coding first exons. These alternative first exons
are located several kilobases upstream of the classic GATA4
transcription initiation site suggesting that their expression is being
driven from novel upstream promoters. The fact that some of
these first exons are species-conserved also indicates that
alternative promoter usage is likely an important regulatory
mechanism for controlling the tissue- and cell-specific expression
of the GATA4 gene in humans and other mammalian species.
As for the other GATA genes, the GATA4 ATG initiator codon
and the start of its open reading frame is located in E2. Its
originally described first exon, which is non-coding, is located 3.5
kb upstream of E2. Other GATA gene family members, however,
are known to express multiple transcripts with different untrans-
lated first exons (reviewed in [32]). Moreover, many of these
alternative GATA transcripts are expressed in a tissue-specific
manner. To determine whether GATA4 is or is not an exception
Figure 5. In vivo detection of Gata4 E1a and E1b mRNA transcripts. In situ hybridization of Gata4 mRNA with a riboprobe corresponding to
the whole Gata4 coding sequence (cds) (A, D), Gata4 E1a (B, E), and Gata4 E1b (C,F) transcripts in mouse male e12.5 embryos (A–C), and male e15.5
testes (D–F). Control E1a and E1b sense probes in male e15.5 testes are shown in the insets to (E) and (F), respectively. An obvious Gata4 signal is
present in testes (t), stomach epithelium (s), intestine epithelium (i), and in liver (li) of e12.5 male embryos with the Gata4 cds and Gata4 E1a probes.
An obvious Gata4 signal (arrows) is also present in Sertoli cells of testicular cords (areas enclosed by dotted lines) of e15.5 male testes with the Gata4
cds and Gata4 E1a probes. Unreactive germ cells are indicated by arrowheads. Scale bars: 100 mm.
doi:10.1371/journal.pone.0008454.g005
Figure 6. Polysome analysis of Gata4 E1a and E1b transcripts in
the testis. RNA from adult mouse testis was centrifuged through a
linear sucrose gradient to separate transcripts associated with mono-
ribosomes (not actively translated) and polyribosomes (actively
translated). Monoribosomal and polyribosomal fractions are found at
the top and towards the bottom of the gradient, respectively. Twelve
fractions were collected from the gradient, the RNA was extracted from
each fraction, reverse-transcribed into cDNA and subjected to PCR with
primers specific for Gata4 E1a and E1b. Both transcripts are associated
with the polyribosomal fractions indicating that they are being actively
translated into protein. EDTA, which sequesters magnesium ions
required for ribosome stability, was used as a control. In the presence
of EDTA, the transcript profiles show a characteristic shift to the top of
the gradient indicating a successful dissociation of the polyribosomes.
doi:10.1371/journal.pone.0008454.g006
Alternative GATA4 Transcripts
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GATA4 transcripts in mouse, rat, and human tissues. Our results
confirmed the existence of additional first exons for the GATA4
gene, located far upstream of E2 (summarized in Figure 1D).
Conventional RT-PCR amplifications followed by sequencing of
the PCR products showed that the novel GATA4 first exons are
used alternatively and rarely in association with one another, the
one exception being in the human (Figure 2B). All of the first exons
are devoid of a translational start point and, thus, will not affect,
the open reading frame coding for the GATA4 protein. Therefore
our data show that the GATA4 gene also exhibits prominent
alternative first exon usage, a feature common to the other GATA
genes [32], as well as many other genes that display complex
temporal and/or spatial expression patterns [41].
Amongst the newly identified first exons, although E1b was well
conserved between rodents and human, E1b9 and E1c were not.
E1b9-containing transcripts were also expressed at very low levels
as determined by qPCR (data not shown). In human tissues, we
amplified transcripts containing E1c intercalated between E1b and
E2. This is similar to a published EST (AK097060) where E1c is
present but connected to E3. For these specific GATA4 transcripts,
the combination of poor conservation and low level of expression
render the biological significance of these transcripts unlikely, as
suggested for the Nr5a1/Sf1 gene [42]. In contrast, E1b was not
only well conserved between rodents and human from a sequence
standpoint, but was also expressed at significant levels in most, if
not all, GATA4-expressing tissues examined (Figures 3A and 4A).
This was particularly true for the testis where E1a and E1b mRNA
levels were comparable. Surprisingly, a previous study by Ohara et
al [30] did not identify the E1b transcript in their 59 RACE screen
of mouse heart and testis. This might simply be due to differences
in experimental procedures as the energy require to denature the
secondary structure of E1b is predicted to be about twice as high
as that needed for E1a (Figure 2C). At least in the heart, it might
also be a reflection of the lower abundance of the E1b transcript.
Although the E1b sequence appears to be conserved for
mammalian GATA4 genes, this may not extend to all vertebrate
species. For example, an analysis of transcription initiation sites in
the zebrafish gata4 gene, has revealed that its ATG initiator codon
is located in its first exon [43], thus ruling out the possibility of
similar mammalian-like alternative 59 untranslated exons. The
absence of alternative first exon usage has also been reported for
the chick Gata6 gene and the zebrafish and Xenopus Gata2 genes
when compared to their orthologous mouse loci [32]. Conse-
quently, the decrease in conservation of alternative 59 leader exons
with species divergence is not unique to GATA4.
While differential first exon usage is common to the mammalian
GATA genes, their functional significance is less clear. For the
hematopoietic GATA1/2/3 subfamily, promoter sequences up-
stream of different non-coding first exons have been shown to
contribute to the tissue-specific expression of the factors. For
example, regulatory sequences upstream of exon 1T direct Gata1
expression specifically in the testis whereas sequences upstream of
exon 1E direct Gata1 expression in blood cells [33]. For the GATA4
gene, however, the use of alternative first exons appears to be less
well correlated with tissue specificity. Indeed, we detected Gata4
E1a- and E1b-containing transcripts in several GATA4-expressing
organs both in rodents and humans (Figure 2B). This suggests that
both transcript variants are expressed in all GATA4-positive cell
types or that they are specific for a cell type in a given organ. In
the adult mouse intestine, where E1a is predominantly expressed,
the pattern of GFP transgene expression directed by promoter
1a sequences correlated well with the in situ hybridization
signal specific for this exon, but did not exactly match with the
endogenous protein localization (Figure 4A–H). Indeed, GFP
staining, as well as E1a mRNA, were present in a majority of
epithelial cells but only in a subset of villosities whereas GATA4
protein could be detected in all villosities. Thus in the intestine
where the epithelium is composed predominantly of enterocytes,
we can speculate that E1a and E1b transcripts complement one
another at a local level. Our demonstration that the Gata4 E1a and
E1b variants are translationally active (Figure 6) supports this
hypothesis. However, in more complex organs such as the gonads
which are composed of different cell types that express GATA4
[6], this picture is less clear due to our inability to obtain a reliable
in situ hybridization signal for the E1b-specific transcript. As a
result, other approaches such as generation of transgenic mice
expressing a reporter gene driven by E1b promoter sequences will
undoubtedly have to be used to answer this question.
It is interesting to note that GATA4 more closely resembles
GATA6 than the hematopoietic GATA factors not only at the
level of coding sequence but also in terms of its transcriptional
regulation. Thus while differential exon 1 usage clearly contributes
to tissue specificity in the case of the hematopoietic GATA1/2/3
subfamily [32], the mostly coordinated exon 1 usage for both
GATA4 (this study) and GATA6 [31] suggests other roles. For
GATA4, redundant transcripts could provide a backup mecha-
nism to guarantee the availability of GATA4 protein in cell types
where its presence is crucial for cell function, such as differenti-
ation of Sertoli cells in the fetal testis [23,24]. The promoter
regulatory sequences driving expression of the different GATA4
transcripts could be under the influence of distinct trans-regulatory
factors and this may account for basal and/or induced GATA4
expression in specific cell types. Alternatively, redundant tran-
scripts might be required to maintain a high level of protein
translation. Finally, the presence of different first exons may play
regulatory roles themselves on either RNA stability, protein
translation efficiency, or both, as it has recently been described for
the Cyp19 gene [44]. Because GATA4 function is paramount for
vertebrate organogenesis, and because its dysregulation is
increasingly being linked to human disease [45], further studies
on the intrinsic properties of each first exon as well as the putative
promoter sequences upstream of E1b will be of great interest to
better understand the complex tissue specification of the GATA4
gene.
Materials and Methods
Ethics Statement
Experiments involving mice or rats were performed following
Canadian Council of Animal Care (CCAC) guidelines for the care
and manipulation of animals used in medical research. Protocols
involving the manipulation of animals were approved by the
institutional ethics committees of the University of Montreal
(comite ´ d’e ´thique de l’utilisation des animaux, CE ´UA) and Laval
University (comite ´ de protection des animaux, CPAUL). Animals
were maintained in ventilated cages under standard conditions of
12 hours of light, 12 hours of dark, with water and commercial
rodent chow provided ad lib.
For experiments involving human tissue samples, McGill
University Health Centre Research ethics boards approved the
studies and informed written consent was obtained in each case.
Collection and Processing of Animal Tissues
Tissues from adult CD-1 mice and Sprague-Dawley rats were
obtained from animals available on site that were euthanized by
CO2 inhalation. Generation of the 5 kb rat Gata4 promoter 1a-
GFP transgenic mouse line has been described previously [29]. For
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observed was designated as e0.5, and for postnatal studies, the day
of birth was designated as P0. Dissected adult organs or embryos
were immediately observed under a standard fluorescence
stereomicroscope for GFP expression in transgenic animals and/
or processed for further morphological analysis or placed in
RNAlater solution (Ambion) and stored at 280uC for subsequent
RNA extraction. For immunohistochemical analyses and in situ
hybridizations, embryos or organs were fixed in 4% paraformal-
dehyde-PBS (pH 7.2) for 1 h to overnight at 4uC. Fixed tissues
were then embedded in paraffin, cut into 7 mm-thick sections, and
mounted on superfrost slides, or cryoprotected in 18% sucrose in
PBS, embedded in Tissue-Tek OCT compound (Miles), cut into
8 mm-thick sections and mounted onto 3-aminopropyltriethoxysi-
lane (Sigma)-treated glass slides and stored at 220uC.
Human Tissues
Testicular and ovarian fetal tissue samples (16 and 19 weeks
fetal age) were obtained after therapeutic abortion [46]. McGill
University Health Centre Research ethics boards approved the
studies and informed written consent was obtained in each case.
Tissues were flash frozen and stored at 280uC until analysis.
59 RACE
Transcriptional start sites of the GATA4 gene were mapped by
rapid amplification of cDNA ends (59 RACE) using the GeneRacer
kit according to instructions supplied by the manufacturer
(Invitrogen). Primers used for the 59 RACE were generated against
exon 2 (E2): one just downstream of the translation initiation start
site and the other, a nested primer located at the beginning of E2
(Table1).TotalcellularRNAusedinthe 59RACEexperimentswas
isolated from different adult mouse and rat tissues using Trizol
reagent according to the manufacturer’s recommendations (Invitro-
gen). RNA from human testis and ovary samples was isolated using
an RNeasy Plus extraction kit (Qiagen). Complementary DNA
(cDNA) was obtained from 5 mg total RNA using random hexamers
and Superscript III reverse transcriptase provided with the
GeneRacer kit. 59 RACE conditions were as follows: 2 min at
95uC,5cycles(95uCfor30 sec,72uCfor45 sec),25cycles(95uCfor
30 sec, 65uC for 30 sec, 72uC for 45 sec), and a final extension of
10 min at 72uC. The reaction product was then used in a second
round of PCR using the same conditions. Amplified products from
the two rounds of nested PCR using the GATA4-specific primers
(Table 1) were subcloned into pCRII-TOPO cloning vector
(Invitrogen) and 46, 16, and 23 individual clones were sequenced
from mouse, rat and human samples, respectively. All novel
GATA4 sequences were deposited in the GenBank database —
mouse: DQ436912, DQ436913, DQ436914, DQ436915; rat:
DQ436916, and human: FJ169610. Sequence homologies between
the different untranslated exons were analyzed using the ISHAN
sequence homology analysis package [47].
Conventional and Quantitative PCR
Conventional PCR was done using Vent polymerase (New
England Biolabs) and a Mastercycler gradient thermocycler
(Eppendorf) under the following conditions—3 min at 95uC
followed by 30 cycles of: denaturation (30 sec at 95uC), annealing
(30 sec at 60uC), extension (30 sec at 72uC), with a final extension
of 5 min at 72uC. PCR products were then analyzed by agarose
gel electrophoresis and ethidium bromide staining. Primers used
for amplification of each alternative first exon are shown in
Table 1. For mouse and rat tissues, each amplification was
performed three times using three different preparations of first
strand cDNAs resulting from three different RNA extractions. Due
to the limited quantity and availability of the human material,
amplifications were done on one sample but from two different
tissues (testis and ovary). In both cases, the amplified products were
found to be identical as verified by sequencing.
For quantitative PCR (qPCR), total RNA was isolated from
mouse tissues as described above. First strand cDNAs were
synthesized from a 2-mg aliquot of the various RNAs using the
Superscript II Reverse Transcriptase System (Invitrogen). Real
time PCR was performed using a LightCycler 1.5 instrument and
the LightCycler FastStart DNA Master SYBR Green I kit (Roche
Diagnostics) according to the manufacturer’s protocol. Primers
used for qPCR are shown in Table 1. All qPCR runs were done
using the following conditions: 10 min at 95uC followed by 35
cycles of denaturation (5 sec at 95uC), annealing (5 sec at 62uC),
and extension (20 sec at 72uC) with a single acquisition of
fluorescence levels at the end of each extension step. Each
amplification was performed in duplicate using at least three
different preparations of first-strand cDNAs prepared from each
organ (n$3). The specificity of the amplified PCR products was
confirmed by analysis of the melting curve and agarose gel
electrophoresis. Differences in mRNA levels between samples were
Table 1. Oligonucleotide primers used in this study.
Primer use Species Sequence
59 RACE (start of exon 2) m/r R: 59-ACCAGAGCGGCTCCAGCGAA-39
59 RACE (start of exon 2) h R: 59-CACAGGCGCAGAAGCTGCTA-39
59 RACE/PCR/qPCR/ISH Gata4 reverse primer (exon 2 after ATG) m/r/h R: 59-CGTGGTTGGCGGCCATGGCCAGGCT-39
PCR Gata4 reverse primer (exon 2) h R: 59-GCGCACCTATTGGGGGCAGAAGAC-39
PCR/qPCR/ISH Gata4 (exon 1a) m/r F: 59-TCCGCGGACTCACGGAGATC-39
PCR Gata4 (exon 1a) h F: 59- GCGGAACCTCCAGGCCCAGCAGG-39
PCR/qPCR/ISH Gata4 (exon 1b) m/r F: 59-ACAGGCTGGAATCTCTGGGCCT-39
PCR Gata4 (exon 1b) h F: 59-CTGGAATCCCTGTGCAGAGTTTGCC-39
PCR Gata4 (exon 1b9) m F: 59-GCTCCCTCCAGCAAACCCAGAT-39
PCR/qPCR Rpl19 mF : 5 9-CTGAAGGTCAAAGGGAATGTG-39
R: 59-GGACAGAGTCTTGATGATCTC-39
m, mouse; r, rat; h, human; F, forward primer; R, reverse primer; ISH, in situ hybridization.
doi:10.1371/journal.pone.0008454.t001
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containing E1a and E1b of the mouse Gata4 gene were amplified
by PCR and cloned into pGEM-T easy vector (Promega) to
generate the E1a and E1b standards for preparing the dilution
curves. A cloned fragment of the ribosomal gene Rpl19 served as
reference gene [48]. Serial dilutions of the target and reference
plasmids ranging from 10
24 (0.1 ng/ml) to 10
27 (0.1 pg/ml) were
prepared to generate the standard curves. The amount of DNA for
the target (E1a, E1b) and reference (Rpl19) in the unknown
samples was calculated by the LightCycler software 3.5 (Roche
Diagnostics) using the respective dilution curves. Data are reported
in arbitrary units as a ratio of the level of Gata4 E1a or E1b mRNA
variant in each sample to that of the Rpl19 reference gene.
In situ Hybridization
Specific mouse Gata4 E1a and E1b cDNAs were generated by
PCR and cloned into pGEM-T easy vector; the corresponding
primers are provided in Table 1. A pcDNA3-GATA4 plasmid
encoding the entire GATA4 coding sequence was used as a control
probe [49]. Digoxigenin-labeled riboprobes were generated by in
vitro transcription using a DIG RNA labeling kit (Roche
Diagnostics). In situ hybridization on frozen tissue sections was
carried out as previously described [50].
Immunohistochemistry
Following paraffin removal and rehydration, endogenous
peroxidase activity was blocked with 0.3% hydrogen peroxide in
methanol for 30 min. Frozen tissue sections were thawed,
delipidized in chloroform, rehydrated in PBS, and endogenous
peroxidase activity was blocked with 3% hydrogen peroxide for
10 min. For GFP and GATA4 immunodetection, sections were
boiledfor5 minin0.1Mcitratebuffer(pH 6.0)forantigenretrieval,
blocked with 10% horse serum (in PBS with 8% BSA) for at least
20 min, and finally incubated overnight at 4uC with primary
antibody diluted in blocking solution (PBS containing 0.1% BSA).
Primary antibodies were directed against GATA4 (diluted 1/1000,
cat. # sc-1237X, Santa Cruz Biotechnology) and GFP (diluted 1/
2000, cat. # RDI-GRNFP4abr, RDI division of Fitzgerald
Industries Intl.). After washing in PBS, sections were incubated
for 45 min with either horseradish peroxidase-conjugated anti-
rabbit antibody (Dako) or biotinylated anti-goat antibody (1/500
dilution; Vector Laboratories) and for 30 min with a peroxidase-
conjugated streptavidin-horseradish complex (LSAB+ Kit; Dako)
for GATA4. The reaction product was developed using 3,39-
diaminobenzidine tetrahydrochloride (Dako). Sections were coun-
terstained with hematoxylin and mounted with glycerol-gelatin
(Sigma). For negative controls, primary antibody was omitted and
this generated no visible reaction. Slides were analyzed with a Zeiss
Akioskop II epifluorescence microscope (Carl Zeiss) connected to a
digital camera (Spot RT Slider, Diagnostic Instruments).
Polysome Analysis
Testes were collected from SV129 adult male mice immediately
after euthanasia and individually pulverized in liquid nitrogen using
a mortar. For each sample, the powder was lysed in 200 mlo f
polysome lysis buffer (PLB) containing 50 mM Tris pH 8.7,
150 mM KCl, 1.25 mM MgCl2, 1% IGEPAL, 0.5% deoxycholate,
10 mM DTT, 100 mg/ml cycloheximide, 1000 U/ml Protector
RNase inhibitor (Roche Diagnostics) and supplemented with
EDTA-free Mini Complete protease inhibitor cocktail (Roche
Diagnostics). A control sample was made by adding EDTA
(100 mM) to the PLB as well as to the sucrose gradient solution.
The presence of EDTA sequesters the magnesium ions required for
ribosome stability. Samples were disrupted by vortexing twice for
10 sec, intermitted by a 30 sec pause and clarified by a 20 min
centrifugation at 12,000 g. Supernatants were assayed for absor-
bance at 260 nm using a NanoDrop ND-1000 spectrophotometer
(Thermo Scientific). Samples (35 OD units) were loaded on a 4 ml
15-45% linear sucrose gradient and centrifuged for 3 h at
34,000 rpm in a SW 60 Ti rotor (Beckman Coulter). Fractionation
was carried out by continuous absorbance monitoring at 254 nm
using the BR-188 Density Gradient Fraction System (Brandel).
Twelve fractions of approximately 350 ml were collected from the
gradient using a Foxy 200 automated fraction collector (Teledyne
Isco) and directly added to 428 ml of 5.25 M guanidinium
thiocyanate. Fractions were precipitated overnight at 220uCb y
adding 2 ml of linear acrylamide (Ambion) used as carrier and
778 mlof100%ethanol.Fractionswerespun at10,000 gfor20 min
at 4uC, washed with 85% ethanol, and spun again at 10,000 g for
20 min. Once the supernatant was discarded, the RNA from each
pellet was further purified using the Picopure RNA isolation kit
(Molecular Devices). An aliquot of each fraction was used to
quantify and assess the integrity of RNA using the 2100 Bioanalyser
RNA 6000 Nano Chip kit (Agilent Technologies). The remaining
total RNA content of each faction was reversed transcribed using
SuperScript II (Invitrogen) following the manufacturer’s protocol.
The reaction was primed using 50 mM of oligo-dT(18). Fractions
were then assayed for the presence of Gata4 E1a or E1b by
conventional PCR as described above.
Statistical Analysis
Statistical analyses were done using the nonparametric Kruskal-
Wallis one-way analysis of variance followed by Mann-Whitney U-
tests to identify significant differences between groups; a P value
less than 0.05 was considered significant. All statistical analyses
were done using the SigmaStat software package (Systat Software).
Supporting Information
Figure S1 MultiPipMaker [52] sequence comparison of GATA4
rat (used as reference sequence), mouse, human and dog loci. The
percent sequence identity per 100 consecutive bp is indicated on
the right. Exons are boxed in blue; highly conserved non-coding
regions are highlighted by a green oval.
Found at: doi:10.1371/journal.pone.0008454.s001 (1.63 MB TIF)
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